心血管护理中的入职肥胖管理:心脏病专家最新进展指南

IF 4.3 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
François Schiele , François Dievart , David Jacobi , Denis Angoulvant , Sebastien Czernichow , Etienne Puymirat , Pierre Sabouret , Victor Aboyans
{"title":"心血管护理中的入职肥胖管理:心脏病专家最新进展指南","authors":"François Schiele ,&nbsp;François Dievart ,&nbsp;David Jacobi ,&nbsp;Denis Angoulvant ,&nbsp;Sebastien Czernichow ,&nbsp;Etienne Puymirat ,&nbsp;Pierre Sabouret ,&nbsp;Victor Aboyans","doi":"10.1016/j.ajpc.2025.100987","DOIUrl":null,"url":null,"abstract":"<div><div>In recent decades, the prevalence of obesity has escalated markedly, becoming a serious epidemic and public health crisis requiring urgent and sustained attention. Obesity is associated with a large number of health conditions, including cardiovascular diseases (CVDs), which contribute to an increase in mortality and overall global health challenge. Despite its high morbidity and mortality, most healthcare practitioners perceive obesity as an outcome of unhealthy lifestyle rather than a disease by itself. As such, obesity is either overlooked or considered a minor risk factor for CVD in clinical practice, among others. Since cardiovascular (CV) causes remain the leading cause of death in patients with obesity, cardiologists are among the most frequently visited healthcare professionals and can play an essential role in addressing this disease. Obesity is a complex, chronic, relapsing yet treatable disease that stems from the disruption in the body's homeostatic, hedonic, and cognitive systems, as a result of an interplay between genetic, metabolic, inflammatory, vascular, environmental and behavioral, and pharmacological factors. With early recognition and assessment, management of this disease can successfully improve life expectancy and reduce CV risk. In this review, a concise overview of obesity was provided, focusing on its pathophysiology, diagnosis, and management. The correlation between obesity and CVDs was further discussed, highlighting the significance of obesity education and management among cardiologists to improve patient outcomes and prevent the progression of obesity and its related comorbidities.</div></div>","PeriodicalId":72173,"journal":{"name":"American journal of preventive cardiology","volume":"22 ","pages":"Article 100987"},"PeriodicalIF":4.3000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Onboarding obesity management in cardiovascular care: A cardiologist's guide to latest advances\",\"authors\":\"François Schiele ,&nbsp;François Dievart ,&nbsp;David Jacobi ,&nbsp;Denis Angoulvant ,&nbsp;Sebastien Czernichow ,&nbsp;Etienne Puymirat ,&nbsp;Pierre Sabouret ,&nbsp;Victor Aboyans\",\"doi\":\"10.1016/j.ajpc.2025.100987\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>In recent decades, the prevalence of obesity has escalated markedly, becoming a serious epidemic and public health crisis requiring urgent and sustained attention. Obesity is associated with a large number of health conditions, including cardiovascular diseases (CVDs), which contribute to an increase in mortality and overall global health challenge. Despite its high morbidity and mortality, most healthcare practitioners perceive obesity as an outcome of unhealthy lifestyle rather than a disease by itself. As such, obesity is either overlooked or considered a minor risk factor for CVD in clinical practice, among others. Since cardiovascular (CV) causes remain the leading cause of death in patients with obesity, cardiologists are among the most frequently visited healthcare professionals and can play an essential role in addressing this disease. Obesity is a complex, chronic, relapsing yet treatable disease that stems from the disruption in the body's homeostatic, hedonic, and cognitive systems, as a result of an interplay between genetic, metabolic, inflammatory, vascular, environmental and behavioral, and pharmacological factors. With early recognition and assessment, management of this disease can successfully improve life expectancy and reduce CV risk. In this review, a concise overview of obesity was provided, focusing on its pathophysiology, diagnosis, and management. The correlation between obesity and CVDs was further discussed, highlighting the significance of obesity education and management among cardiologists to improve patient outcomes and prevent the progression of obesity and its related comorbidities.</div></div>\",\"PeriodicalId\":72173,\"journal\":{\"name\":\"American journal of preventive cardiology\",\"volume\":\"22 \",\"pages\":\"Article 100987\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-04-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of preventive cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666667725000595\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of preventive cardiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666667725000595","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

近几十年来,肥胖症的发病率明显上升,已成为一种严重的流行病和公共卫生危机,亟需持续关注。肥胖与包括心血管疾病(CVDs)在内的大量健康问题相关,导致死亡率上升,给全球健康带来全面挑战。尽管肥胖症的发病率和死亡率很高,但大多数医疗从业人员认为肥胖症是不健康生活方式的结果,而非疾病本身。因此,在临床实践中,肥胖要么被忽视,要么被认为是心血管疾病的次要风险因素。由于心血管疾病仍然是肥胖症患者的主要死因,因此心脏病专家是最常就诊的医疗保健专业人员之一,在应对这一疾病方面发挥着至关重要的作用。肥胖症是一种复杂、慢性、易复发但可治疗的疾病,它源于遗传、新陈代谢、炎症、血管、环境和行为以及药物等因素的相互作用,破坏了人体的稳态、享乐和认知系统。通过早期识别和评估,这种疾病的治疗可以成功地延长患者的寿命并降低心血管疾病的风险。本综述简要概述了肥胖症的病理生理学、诊断和管理。文章进一步讨论了肥胖与心血管疾病之间的相关性,强调了心脏病专家开展肥胖症教育和管理以改善患者预后、预防肥胖症进展及其相关合并症的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Onboarding obesity management in cardiovascular care: A cardiologist's guide to latest advances
In recent decades, the prevalence of obesity has escalated markedly, becoming a serious epidemic and public health crisis requiring urgent and sustained attention. Obesity is associated with a large number of health conditions, including cardiovascular diseases (CVDs), which contribute to an increase in mortality and overall global health challenge. Despite its high morbidity and mortality, most healthcare practitioners perceive obesity as an outcome of unhealthy lifestyle rather than a disease by itself. As such, obesity is either overlooked or considered a minor risk factor for CVD in clinical practice, among others. Since cardiovascular (CV) causes remain the leading cause of death in patients with obesity, cardiologists are among the most frequently visited healthcare professionals and can play an essential role in addressing this disease. Obesity is a complex, chronic, relapsing yet treatable disease that stems from the disruption in the body's homeostatic, hedonic, and cognitive systems, as a result of an interplay between genetic, metabolic, inflammatory, vascular, environmental and behavioral, and pharmacological factors. With early recognition and assessment, management of this disease can successfully improve life expectancy and reduce CV risk. In this review, a concise overview of obesity was provided, focusing on its pathophysiology, diagnosis, and management. The correlation between obesity and CVDs was further discussed, highlighting the significance of obesity education and management among cardiologists to improve patient outcomes and prevent the progression of obesity and its related comorbidities.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
American journal of preventive cardiology
American journal of preventive cardiology Cardiology and Cardiovascular Medicine
CiteScore
6.60
自引率
0.00%
发文量
0
审稿时长
76 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信